432 related articles for article (PubMed ID: 18166182)
21. Effects of gonadotropin-releasing hormone agonist/recombinant follicle-stimulating hormone versus gonadotropin-releasing hormone antagonist/recombinant follicle-stimulating hormone on follicular fluid levels of adhesion molecules during in vitro fertilization.
Fornaro F; Cobellis L; Mele D; Tassou A; Badolati B; Sorrentino S; De Lucia D; Colacurci N
Fertil Steril; 2007 Jan; 87(1):39-47. PubMed ID: 17084393
[TBL] [Abstract][Full Text] [Related]
22. A controlled trial of natural cycle versus microdose gonadotropin-releasing hormone analog flare cycles in poor responders undergoing in vitro fertilization.
Morgia F; Sbracia M; Schimberni M; Giallonardo A; Piscitelli C; Giannini P; Aragona C
Fertil Steril; 2004 Jun; 81(6):1542-7. PubMed ID: 15193474
[TBL] [Abstract][Full Text] [Related]
23. Circulating level of macrophage colony-stimulating factor can be predictive for human in vitro fertilization outcome.
Salmassi A; Mettler L; Jonat W; Buck S; Koch K; Schmutzler AG
Fertil Steril; 2010 Jan; 93(1):116-23. PubMed ID: 18996518
[TBL] [Abstract][Full Text] [Related]
24. A prospective, randomized, controlled trial comparing three different gonadotropin regimens in oocyte donors: ovarian response, in vitro fertilization outcome, and analysis of cost minimization.
Melo M; Bellver J; Garrido N; Meseguer M; Pellicer A; Remohí J
Fertil Steril; 2010 Aug; 94(3):958-64. PubMed ID: 19931075
[TBL] [Abstract][Full Text] [Related]
25. Clinical efficacy of highly purified urinary FSH versus recombinant FSH in volunteers undergoing controlled ovarian stimulation for in vitro fertilization: a randomized, multicenter, investigator-blind trial.
Baker VL; Fujimoto VY; Kettel LM; Adamson GD; Hoehler F; Jones CE; Soules MR
Fertil Steril; 2009 Apr; 91(4):1005-11. PubMed ID: 18367182
[TBL] [Abstract][Full Text] [Related]
26. Tamoxifen co-administration during controlled ovarian hyperstimulation for in vitro fertilization in breast cancer patients increases the safety of fertility-preservation treatment strategies.
Meirow D; Raanani H; Maman E; Paluch-Shimon S; Shapira M; Cohen Y; Kuchuk I; Hourvitz A; Levron J; Mozer-Mendel M; Brengauz M; Biderman H; Manela D; Catane R; Dor J; Orvieto R; Kaufman B
Fertil Steril; 2014 Aug; 102(2):488-495.e3. PubMed ID: 24934489
[TBL] [Abstract][Full Text] [Related]
27. Comparison of luteal estradiol patch and gonadotropin-releasing hormone antagonist suppression protocol before gonadotropin stimulation versus microdose gonadotropin-releasing hormone agonist protocol for patients with a history of poor in vitro fertilization outcomes.
Weitzman VN; Engmann L; DiLuigi A; Maier D; Nulsen J; Benadiva C
Fertil Steril; 2009 Jul; 92(1):226-30. PubMed ID: 18675961
[TBL] [Abstract][Full Text] [Related]
28. Using the ovarian sensitivity index to define poor, normal, and high response after controlled ovarian hyperstimulation in the long gonadotropin-releasing hormone-agonist protocol: suggestions for a new principle to solve an old problem.
Huber M; Hadziosmanovic N; Berglund L; Holte J
Fertil Steril; 2013 Nov; 100(5):1270-6. PubMed ID: 23931964
[TBL] [Abstract][Full Text] [Related]
29. Microdose gonadotropin-releasing hormone agonist flare-up protocol versus multiple dose gonadotropin-releasing hormone antagonist protocol in poor responders undergoing intracytoplasmic sperm injection-embryo transfer cycle.
Kahraman K; Berker B; Atabekoglu CS; Sonmezer M; Cetinkaya E; Aytac R; Satiroglu H
Fertil Steril; 2009 Jun; 91(6):2437-44. PubMed ID: 18555238
[TBL] [Abstract][Full Text] [Related]
30. Anti-Müllerian hormone and inhibin B as predictors of pregnancy after treatment by in vitro fertilization/intracytoplasmic sperm injection.
Wunder DM; Guibourdenche J; Birkhäuser MH; Bersinger NA
Fertil Steril; 2008 Dec; 90(6):2203-10. PubMed ID: 18291376
[TBL] [Abstract][Full Text] [Related]
31. [Clinical application of prefilled pen and conventional syringe during controlled ovarian stimulation for in vitro fertilization].
Chen LN; Quan S; Li H; Yang XP; Chen SM; Zhang XY; Lin L; Xing FQ; Chen SL; Wan ZJ; Wang Y
Nan Fang Yi Ke Da Xue Xue Bao; 2009 Jan; 29(1):100-4. PubMed ID: 19218125
[TBL] [Abstract][Full Text] [Related]
32. A randomized, controlled, pilot trial on the effect of dehydroepiandrosterone on ovarian response markers, ovarian response, and in vitro fertilization outcomes in poor responders.
Yeung TW; Chai J; Li RH; Lee VC; Ho PC; Ng EH
Fertil Steril; 2014 Jul; 102(1):108-115.e1. PubMed ID: 24796766
[TBL] [Abstract][Full Text] [Related]
33. Corifollitropin alfa followed by rFSH in a GnRH antagonist protocol for poor ovarian responder patients: an observational pilot study.
Polyzos NP; Devos M; Humaidan P; Stoop D; Ortega-Hrepich C; Devroey P; Tournaye H
Fertil Steril; 2013 Feb; 99(2):422-6. PubMed ID: 23084565
[TBL] [Abstract][Full Text] [Related]
34. Clinical and endocrine response to the withdrawal of gonadotropin-releasing hormone agonists during prolonged coasting.
Ho Yuen B; Nguyen TA; Cheung AP; Leung PC
Fertil Steril; 2009 Aug; 92(2):499-507. PubMed ID: 18706551
[TBL] [Abstract][Full Text] [Related]
35. Elevated early follicular progesterone levels and in vitro fertilization outcomes: a prospective intervention study and meta-analysis.
Hamdine O; Macklon NS; Eijkemans MJ; Laven JS; Cohlen BJ; Verhoeff A; van Dop PA; Bernardus RE; Lambalk CB; Oosterhuis GJ; Holleboom CA; van den Dool-Maasland GC; Verburg HJ; van der Heijden PF; Blankhart A; Fauser BC; Broekmans FJ;
Fertil Steril; 2014 Aug; 102(2):448-454.e1. PubMed ID: 24929258
[TBL] [Abstract][Full Text] [Related]
36. Are gonadotropin-releasing hormone agonists losing popularity? Current trends at a large fertility center.
Reh A; Krey L; Noyes N
Fertil Steril; 2010 Jan; 93(1):101-8. PubMed ID: 18973891
[TBL] [Abstract][Full Text] [Related]
37. A comparison of 3-day and daily follicle-stimulating hormone injections on stimulation days 1-6 in women undergoing controlled ovarian hyperstimulation.
Scholtes MC; Schnittert B; van Hoogstraten D; Verhoeven HC; Zrener A; Warne DW
Fertil Steril; 2004 Apr; 81(4):996-1001. PubMed ID: 15066454
[TBL] [Abstract][Full Text] [Related]
38. Couples with unexplained subfertility and unfavorable prognosis: a randomized pilot trial comparing the effectiveness of in vitro fertilization with elective single embryo transfer versus intrauterine insemination with controlled ovarian stimulation.
Custers IM; König TE; Broekmans FJ; Hompes PG; Kaaijk E; Oosterhuis J; Mochtar MH; Repping S; van Wely M; Steures P; van der Veen F; Mol BW
Fertil Steril; 2011 Nov; 96(5):1107-11.e1. PubMed ID: 21890134
[TBL] [Abstract][Full Text] [Related]
39. A comparison study of a novel stimulation protocol and the conventional low dose step-up and step-down regimens in patients with polycystic ovary syndrome undergoing in vitro fertilization.
Koundouros SN
Fertil Steril; 2008 Sep; 90(3):569-75. PubMed ID: 17880950
[TBL] [Abstract][Full Text] [Related]
40. Administration of a gonadotropin-releasing hormone antagonist during the 3 days before the initiation of the in vitro fertilization/intracytoplasmic sperm injection treatment cycle: impact on ovarian stimulation. A pilot study.
Blockeel C; Riva A; De Vos M; Haentjens P; Devroey P
Fertil Steril; 2011 Apr; 95(5):1714-9.e1-2. PubMed ID: 21300334
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
